Impact of Anatomical Site on RNA-based molecular subtypes in High -Grade Serous tubo-Ovarian Carcinoma Samples
Reproductive Sciences
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD)-a multinational team initiative
Gynecologic Oncology
DOI:
10.1016/J.YGYNO.2026.04.008
Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher and Kylie L. Gorringe and Matthew Wakefield and Adelyn Bolithon and Chi Nam Ignatius Pang and Derek S. Chiu and Michael S. Anglesio and Kylie-Ann Mallitt and Jennifer A. Doherty and Holly R. Harris and Joellen M. Schildkraut and Andrew Berchuck and Kara L. Cushing-Haugen and Ksenia Chezar and Angela Chou and Adeline Tan and Jennifer Alsop and Ellen Barlow and Matthias W. Beckmann and Jessica Boros and David D.L. Bowtell and Alison H. Brand and James D. Brenton and Ian Campbell and Dane Cheasley and Joshua Cohen and Cezary Cybulski and Esther Elishaev and Ramona Erber and Rhonda Farrell and Anna Fischer and Zhuxuan Fu and Blake Gilks and Anthony J. Gill and Charlie Gourley and Marcel Grube and Paul R. Harnett and Arndt Hartmann and Anusha Hettiaratchi and Claus K. Hgdall and Tomasz Huzarski and Anna Jakubowska and Mercedes Jimenez-Linan and Catherine J. Kennedy and Byoung-Gie Kim and Jae-Weon Kim and Jae-Hoon Kim and Kayla Klett and Jennifer M. Koziak and Tiffany Lai
DOI:
10.1158/1078-0432.30706368
11 / 2025
Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher and Kylie L. Gorringe and Matthew Wakefield and Adelyn Bolithon and Chi Nam Ignatius Pang and Derek S. Chiu and Michael S. Anglesio and Kylie-Ann Mallitt and Jennifer A. Doherty and Holly R. Harris and Joellen M. Schildkraut and Andrew Berchuck and Kara L. Cushing-Haugen and Ksenia Chezar and Angela Chou and Adeline Tan and Jennifer Alsop and Ellen Barlow and Matthias W. Beckmann and Jessica Boros and David D.L. Bowtell and Alison H. Brand and James D. Brenton and Ian Campbell and Dane Cheasley and Joshua Cohen and Cezary Cybulski and Esther Elishaev and Ramona Erber and Rhonda Farrell and Anna Fischer and Zhuxuan Fu and Blake Gilks and Anthony J. Gill and Charlie Gourley and Marcel Grube and Paul R. Harnett and Arndt Hartmann and Anusha Hettiaratchi and Claus K. Hgdall and Tomasz Huzarski and Anna Jakubowska and Mercedes Jimenez-Linan and Catherine J. Kennedy and Byoung-Gie Kim and Jae-Weon Kim and Jae-Hoon Kim and Kayla Klett and Jennifer M. Koziak and Tiffany Lai
DOI:
10.1158/1078-0432.30706371
11 / 2025
Data from A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer
Fabian Coscia and Annelaura B. Nielsen and Melanie Weigert and Karen Watters and Melissa Javellana and Michael Anglesio and S. Diane Yamada and Ricardo R. Lastra and Matthias Mann and Ernst Lengyel
DOI:
10.1158/1078-0432.c.7854080
06 / 2025
Homologous recombination DNA repair dependent survival associations in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis consortium study
Cancer Research
DOI:
10.1158/1538-7445.OVARIAN25-B046
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity
International Journal of Gynecological Cancer
DOI:
10.1016/J.IJGC.2025.101957
Cellular origins of mucinous ovarian carcinoma
The Journal of Pathology
DOI:
10.1002/PATH.6407
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-24-1763
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Cancer Epidemiology Biomarkers & Prevention
DOI:
10.1158/1055-9965.EPI-24-1143
Abstract B007: Parallel epigenetic and transcriptomic profiling of carcinoma and stroma compartments across major ovarian cancer histotypes
Cancer Research
DOI:
10.1158/1538-7445.OVARIAN25-B007
WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Homologous): homologous rodent models (vol 31,gaaf021,2025)
Molecular Human Reproduction
DOI:
10.1093/MOLEHR/GAAF036
WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Homologous): homologous rodent models
Molecular Human Reproduction
DOI:
10.1093/MOLEHR/GAAF021
NGS Compartment Analysis Revealed Uniformity within the Stroma and Type-Specific Differences in the Epithelium of EndometriosisAssociated and High-Grade Serous Ovarian Carcinomas
Reproductive Sciences
Synchronous endometrial and ovarian cancer (SEOC): refining pathological and molecular context to identify 'low-risk SEOC'
International Journal of Gynecological Cancer
DOI:
10.1136/IJGC-2024-IGCS.44
Somatic PTEN and ARID1A loss and endometriosis disease burden: a longitudinal study
Human Reproduction
DOI:
10.1093/HUMREP/DEAE269
Precision medicine opportunities: uniformity across stromal components of ovarian cancer histotype contrasts heterogeneous disease
Cancer Research
DOI:
10.1158/1538-7445.OVARIAN23-B004
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7
Laboratory Investigation
DOI:
10.1016/J.LABINV.2023.100321
Association of Somatic Loss of PTEN and ARID1A with Endometriosis Disease Burden: A Longitudinal Study.
REPRODUCTIVE SCIENCES
Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes
Cancer Research
DOI:
10.1158/0008-5472.CAN-23-1362
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
Journal of Clinical Investigation
DOI:
10.1172/JCI179501
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-23-3552
Association of Somatic Loss of PTEN and ARID1A with Endometriosis Disease Burden: A Longitudinal Study
Reproductive Sciences
M2 Macrophages are Major Mediators of Germline Risk of Endometriosis and Explain Pleiotropy with Comorbid Traits
bioRxiv
DOI:
10.1101/2024.11.21.624726
NGS Compartment Analysis Revealed Uniformity within the Stroma and Type-Specific Differences in the Epithelium of EndometriosisAssociated and High-Grade Serous Ovarian Carcinomas.
REPRODUCTIVE SCIENCES
Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher and Kylie L. Gorringe and Matthew Wakefield and Adelyn Bolithon and Chi Nam Ignatius Pang and Derek S. Chiu and Michael S. Anglesio and Kylie-Ann Mallitt and Jennifer A. Doherty and Holly R. Harris and Joellen M. Schildkraut and Andrew Berchuck and Kara L. Cushing-Haugen and Ksenia Chezar and Angela Chou and Adeline Tan and Jennifer Alsop and Ellen Barlow and Matthias W. Beckmann and Jessica Boros and David D.L. Bowtell and Alison H. Brand and James D. Brenton and Ian Campbell and Dane Cheasley and Joshua Cohen and Cezary Cybulski and Esther Elishaev and Ramona Erber and Rhonda Farrell and Anna Fischer and Zhuxuan Fu and Blake Gilks and Anthony J. Gill and Charlie Gourley and Marcel Grube and Paul R. Harnett and Arndt Hartmann and Anusha Hettiaratchi and Claus K. Hgdall and Tomasz Huzarski and Anna Jakubowska and Mercedes Jimenez-Linan and Catherine J. Kennedy and Byoung-Gie Kim and Jae-Weon Kim and Jae-Hoon Kim and Kayla Klett and Jennifer M. Koziak and Tiffany Lai
DOI:
10.1158/1078-0432.c.6532782
04 / 2023
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
BRITISH JOURNAL OF CANCER
DOI:
10.1038/S41416-022-02014-Y
Single-cell transcriptomic analysis of endometriosis
NATURE GENETICS
DOI:
10.1038/S41588-022-01254-1
Neuroproliferative dyspareunia in endometriosis and vestibulodynia
Sexual Medicine Reviews
DOI:
10.1093/SXMREV/QEAD033
KRAS mutations and endometriosis burden of disease
JOURNAL OF PATHOLOGY CLINICAL RESEARCH
DOI:
10.1002/CJP2.317
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
CANCER
DOI:
10.1002/CNCR.34582
A DMBA-induced ovarian cancer model: Could it be clinically useful to test OncoTherad and erythropoietin as anticancer approaches?
Journal of Clinical Oncology
DOI:
10.1200/JCO.2023.41.16_SUPPL.E17589
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-22-381
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Journal of Pathology Clinical Research
DOI:
10.1002/CJP2.311
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
DOI:
10.1158/1055-9965.EPI-22-0941
ADVISE: Endometrial and Ovarian Cancer screening using vaginal-based liquid biopsies
Bioinformatics, Interdisciplinary Oncology and Genome Science + Technology - BIG 22
Rushton C, Anna T, Senz J, Alcaide M, Shen C, Wan R, Ruffin K, Morin RD, Anglesio MS., ADVISE: Endometrial and Ovarian Cancer screening using vaginal-based liquid biopsies. Bioinformatics, Interdisciplinary Oncology and Genome Science + Technology - BIG 22; 2022 March 23, 2022; Vancouver, Canada: University of British Columbia.
03 / 2022
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
VIRCHOWS ARCHIV
DOI:
10.1007/S00428-021-03232-0
Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
DOI:
10.1097/PGP.0000000000000780
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-21-3817
Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer
GYNECOLOGIC ONCOLOGY
DOI:
10.1016/J.YGYNO.2022.07.020
LYMPHADENECTOMY IN ENDOMETRIOID OVARIAN CARCINOMA PATIENTS WITH EARLY STAGE DISEASE: RESULTS FROM THE LEOPARD TRIAL
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1136/IJGC-2022-IGCS.33
Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?
GYNECOLOGIC ONCOLOGY REPORTS
DOI:
10.1016/J.GORE.2022.101076
Immunohistochemical Profiles Including p53, MMR, PR and CTNNB1 are Associated with Survival of Patients Diagnosed with Ovarian Endometrioid Carcinoma
LABORATORY INVESTIGATION
The proteome of clear cell ovarian carcinoma
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.6006
Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia
JOURNAL OF IMMUNOLOGY
DOI:
10.4049/JIMMUNOL.208.SUPP.179.04
Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes
FERTILITY AND STERILITY
DOI:
10.1016/J.FERTNSTERT.2022.05.030
Metastasis in endometriosis: targeted sequencing suggests non-malignancy associated endometriosis is capable of wide dissemination
GEBURTSHILFE UND FRAUENHEILKUNDE
DOI:
10.1055/S-0042-1756999
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-22-1206
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.5849
Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
JOURNAL OF PATHOLOGY CLINICAL RESEARCH
DOI:
10.1002/CJP2.243
Somatic Genomic Events in Endometriosis: Review of the Literature and Approach to Phenotyping
Reproductive Sciences
Paul J. Yong and Aline Talhouk and Michael S. Anglesio
DOI:
10.1007/s43032-020-00451-9
10 / 2021
Pathogenesis of bowel endometriosis
Best Practice & Research Clinical Obstetrics & Gynaecology
Paul J. Yong and Mohamed A. Bedaiwy and Fahad Alotaibi and Michael S. Anglesio
DOI:
10.1016/j.bpobgyn.2020.05.009
03 / 2021
Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes.
medRxiv
DOI:
10.1101/2021.04.12.21255355
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma
MedRxiv
DOI:
10.1101/2021.09.16.21262993
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
MODERN PATHOLOGY
DOI:
10.1038/S41379-020-0618-9
Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
DOI:
10.1007/S00432-021-03558-X
Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
NUCLEAR FEATURES ALLOW FOR HIGHLY SENSITIVE SELECTION OF ENDOMETRIAL CARCINOMAS FOR P53 TESTING
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1136/IJGC-2021-IGCS.173
Prognostic and theragnostic biomarkers in ovarian clear cell carcinoma
Katharina Wiedemeyer and Linyuan Wang and Eun Young Kang and Shuhong Liu and Young Ou and Linda E. Kelemen and Lukas Feil and Michael S. Anglesio and Sarah Glaze and Prafull Ghatage and Gregg S. Nelson and Martin Kbel
DOI:
10.1101/2020.08.21.20178830
08 / 2020
Immunohistochemical Expression of L1CAM in Endometrioid Ovarian Cancer - A new Prognostic Marker?
GEBURTSHILFE UND FRAUENHEILKUNDE
DOI:
10.1055/S-0040-1718139
Application of the molecular Risk Stratification of the Endometrium to endometrioid Ovarian Carcinoma - a retrospective, international Multicenter Study
GEBURTSHILFE UND FRAUENHEILKUNDE
DOI:
10.1055/S-0040-1718219
The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer.
CLINICAL CANCER RESEARCH
The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer
Clinical Cancer Research
PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer.
CLINICAL CANCER RESEARCH
Molecular stratification of clear cell ovarian carcinomas
GEBURTSHILFE UND FRAUENHEILKUNDE
DOI:
10.1055/S-0040-1718135
Endometrial cancer molecular risk stratification in endometrioid ovarian cancers: A novel application of precision medicine
Clinical Cancer Research
Histotype-specific analysis of acid ceramidase expression in ovarian cancer
VIRCHOWS ARCHIV
DOI:
10.1007/S00428-019-02728-0
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-20-1268
STUDY IN PROGRESS: INTERNATIONAL RETROSPECTIVE STUDY ON LYMPHADENECTOMY IN ENDOMETRIOID OVARIAN CARCINOMA PATIENTS WITH EARLY STAGE DISEASE (LEOPARD)
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1136/IJGC-2020-IGCS.394
Prognostic gene expression signature for high-grade serous ovarian cancer
ANNALS OF ONCOLOGY
DOI:
10.1016/J.ANNONC.2020.05.019
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
BRITISH JOURNAL OF CANCER
DOI:
10.1038/S41416-020-0900-0
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer
CANCERS
DOI:
10.3390/CANCERS12123828
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-20-0103
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
GYNECOLOGIC ONCOLOGY
DOI:
10.1016/J.YGYNO.2020.06.481
Endometrial cancer molecular risk stratification in endometrioid ovarian cancers: A novel application of precision medicine.
CLINICAL CANCER RESEARCH
ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation
CELL REPORTS
DOI:
10.1016/J.CELREP.2020.108366
PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer
Clinical Cancer Research
DOI:
10.1158/1557-3265.OVCA19-A03
Is endometriosis metastasizing? Shared somatic alterations suggest common origins across endometriotic lesions
GEBURTSHILFE UND FRAUENHEILKUNDE
DOI:
10.1055/S-0040-1718045
The molecular origin and taxonomy of mucinous ovarian carcinoma
Nature Communications
Dane Cheasley and Matthew J. Wakefield and Georgina L. Ryland and Prue E. Allan and Kathryn Alsop and Kaushalya C. Amarasinghe and Sumitra Ananda and Michael S. Anglesio and George Au-Yeung and Maret Bhm and David D. L. Bowtell and Alison Brand and Georgia Chenevix-Trench and Michael Christie and Yoke-Eng Chiew and Michael Churchman and Anna DeFazio and Renee Demeo and Rhiannon Dudley and Nicole Fairweather and Clare G. Fedele and Sian Fereday and Stephen B. Fox and C Blake Gilks and Charlie Gourley and Neville F. Hacker and Alison M. Hadley and Joy Hendley and Gwo-Yaw Ho and Siobhan Hughes and David G. Hunstman and Sally M. Hunter and Tom W. Jobling and Kimberly R. Kalli and Scott H. Kaufmann and Catherine J. Kennedy and Martin Kbel and Cecile Le Page and Jason Li and Richard Lupat and Orla M. McNally and Jessica N. McAlpine and Anne-Marie Mes-Masson and Linda Mileshkin and Diane M. Provencher and Jan Pyman and Kurosh Rahimi and Simone M. Rowley and Carolina Salazar and Goli Samimi
DOI:
10.1038/s41467-019-11862-x
09 / 2019
TRANSLATING ENDOMETRIAL MOLECULAR RISK STRATIFICATION TO ENDOMETRIOID OVARIAN CARCINOMA: A NOVEL APPLICATION OF PRECISION MEDICINE
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1136/IJGC-2019-IGCS.3
THE PROGNOSTIC IMPACT OF SPHINGOSINE-KINASE 1 EXPRESSION (SPHK1) ON OVARIAN CANCER
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1136/IJGC-2019-ESGO.882
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Cancers
MODERN PATHOLOGY
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
MODERN PATHOLOGY
DOI:
10.1038/S41379-019-0302-0
Nuclear -catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome
HISTOPATHOLOGY
DOI:
10.1111/HIS.13772
Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-18-3241
Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
DOI:
10.1007/S00432-019-02986-0
APPLICATION OF PRECISION MEDICINE: CAN MOLECULAR RISK STRATIFICATION PROVIDE NEW MANAGEMENT OPTIONS FOR LOW STAGE ENDOMETRIOID OVARIAN CARCINOMA?
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1136/IJGC-2019-ESGO.41
Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-18-3720
Optimized molecular risk stratification for ovarian endometrioid carcinomas
Modern Pathology
Oncogenic mutations in histologically normal endometrium: the new normal?
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.5314
Iatrogenic endometriosis harbors somatic cancer-driver mutations
HUMAN REPRODUCTION
DOI:
10.1093/HUMREP/DEY332
HACE1 is a potential tumor suppressor in osteosarcoma
CELL DEATH & DISEASE
DOI:
10.1038/S41419-018-1276-4
Advanced Methods for Cancer Detection by Vaginal Screening (ADVISE): Feasibility and Assessment of Deep-Sequencing Based Self-Sampling Methods
British Columbia Cancer Symposium
Rushton C, Tinker AV, Yang W, Yun JP, Rufin K, Alcaide M, Morin RD, Anglesio MS., Advanced Methods for Cancer Detection by Vaginal Screening (ADVISE): Feasibility and Assessment of Deep-Sequencing Based Self-Sampling Methods. British Columbia Cancer Symposium; 2018; Vancouver, BC, Canada: BCCA.
11 / 2018
You won't believe this old test that does cheap single-cell mutation detection
The Journal of Pathology: Clinical Research
Martin Kbel and Michael S. Anglesio and James D. Brenton
DOI:
10.1002/cjp2.108
07 / 2018
Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging
Modern Pathology
Naveena Singh and Asma Faruqi and Friedrich Kommoss and W Glenn McCluggage and Giorgia Trevisan and Janine Senz and Amy Lum and C Blake Gilks and Michael Anglesio
DOI:
10.1038/modpathol.2017.159
04 / 2018
Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage
International Journal of Gynecological Pathology
DOI:
10.1097/PGP.0000000000000429
Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development
ECANCERMEDICALSCIENCE
DOI:
10.3332/ECANCER.2018.803
Capturing L1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers as a way to track tumor development.
CLINICAL CANCER RESEARCH
Cancer Associated Mutations in Eutopic Endometrium
LABORATORY INVESTIGATION
CLINICAL AND MOLECULAR CHARACTERIZATION OF SYNCHRONOUS ENDOMETRIAL AND OVARIAN CARCINOMAS
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Capturing L1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers as a way to track tumor development
Clinical Cancer Research
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
JOURNAL OF PATHOLOGY CLINICAL RESEARCH
DOI:
10.1002/CJP2.109
A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.
JOURNAL OF CLINICAL ONCOLOGY
DOI:
10.1200/JCO.2018.36.15_SUPPL.5583
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
CELL
DOI:
10.1016/J.CELL.2018.03.073
Histotype classification of ovarian carcinoma: A comparison of approaches
GYNECOLOGIC ONCOLOGY
DOI:
10.1016/J.YGYNO.2018.08.016
Somatic Cancer-Driver Alterations Among Benign Endometriosis Subtypes
MODERN PATHOLOGY
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Nature Genetics
Yi Kan Wang and Ali Bashashati and Michael S Anglesio and Dawn R Cochrane and Diljot S Grewal and Gavin Ha and Andrew McPherson and Hugo M Horlings and Janine Senz and Leah M Prentice and Anthony N Karnezis and Daniel Lai and Mohamed R Aniba and Allen W Zhang and Karey Shumansky and Celia Siu and Adrian Wan and Melissa K McConechy and Hector Li-Chang and Alicia Tone and Diane Provencher and Manon de Ladurantaye and Hubert Fleury and Aikou Okamoto and Satoshi Yanagida and Nozomu Yanaihara and Misato Saito and Andrew J Mungall and Richard Moore and Marco A Marra and C Blake Gilks and Anne-Marie Mes-Masson and Jessica N McAlpine and Samuel Aparicio and David G Huntsman and Sohrab P Shah
DOI:
10.1038/ng.3849
06 / 2017
Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma
MOLECULAR CANCER RESEARCH
DOI:
10.1158/1541-7786.MCR-16-0132
Identical TP53 mutations provide evidence that late-recurring tubo-ovarian high-grade serous carcinomas do not represent new peritoneal primaries
HISTOPATHOLOGY
DOI:
10.1111/HIS.13327
EXPRESSION OF ACID CERAMIDASE (ASAH1) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER
International Journal of Gynecological Cancer
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation
PLOS ONE
DOI:
10.1371/JOURNAL.PONE.0178989
Cancer-Associated Mutations in Endometriosis without Cancer
NEW ENGLAND JOURNAL OF MEDICINE
DOI:
10.1056/NEJMOA1614814
APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner
GYNECOLOGIC ONCOLOGY
DOI:
10.1016/J.YGYNO.2017.10.016
LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers
GYNECOLOGIC ONCOLOGY
DOI:
10.1016/J.YGYNO.2017.09.032
Endometriosis-associated Ovarian Cancers
CLINICAL OBSTETRICS AND GYNECOLOGY
DOI:
10.1097/GRF.0000000000000320
Enhanced GAB2 Expression Is Associated with Improved Survival in High-grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition (vol 14, pg 1495, 2015)
MOLECULAR CANCER THERAPEUTICS
DOI:
10.1158/1535-7163.MCT-17-0067
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
CANCER
DOI:
10.1002/CNCR.30496
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver (vol 20, pg 6618, 2014)
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-16-0992
IS ENDOMETRIOSIS A NEOPLASM AND IS THERE AN OPPORTUNITY FOR A BIOLOGICALLY INFORMED CLASSIFICATION SYSTEM?
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction
PLOS ONE
DOI:
10.1371/JOURNAL.PONE.0153844
BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1097/IGC.0000000000000698
Genomics analyses of less common epithelial ovarian cancer subtypes.
CLINICAL CANCER RESEARCH
DOI:
10.1158/1557-3265.OVCA15-B08
Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines
AMERICAN JOURNAL OF CANCER RESEARCH
Synchronous ovarian and endometrial carcinomas: The case for pseudo-metastasis
CLINICAL CANCER RESEARCH
DOI:
10.1158/1557-3265.OVCA15-PR07
Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
DOI:
10.1093/JNCI/DJV428
Genomic consequences of aberrant DNA repair stratify ovarian cancer histotypes
CANCER RESEARCH
DOI:
10.1158/1538-7445.AM2016-LB-324
Recurrent DICER1 Hotspot Mutations in Endometrial Tumours And Their Impact on MicroRNA Biogenesis.
Chen J and Wang Y and McMonechy MK and Anglesio MS and Yang W and Senz J and Maines-Bandiera S and Rosner J and Trigo-Gonzalez G and Grace Cheng SW and Kim J and Matzuk MM and Morin GB and Huntsman DG
PubMed:
26033159
06 / 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition
MOLECULAR CANCER THERAPEUTICS
DOI:
10.1158/1535-7163.MCT-15-0039
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
DOI:
10.1097/IGC.0000000000000492
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
ONCOTARGET
DOI:
10.18632/ONCOTARGET.5438
The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors
CLINICAL CANCER RESEARCH
DOI:
10.1158/1557-3265.OVCASYMP14-POSTER-BIOL-1349
Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
DOI:
10.1097/PAS.0000000000000476
Molecular Characteristics of Mixed Ovarian Carcinomas
MODERN PATHOLOGY
The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors
NEOPLASIA
DOI:
10.1016/J.NEO.2015.08.003
The somatic mutational landscape of endometriosis associated ovarian cancers and precursor lesions
CLINICAL CANCER RESEARCH
DOI:
10.1158/1557-3265.OVCASYMP14-AS18
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
BMC CANCER
DOI:
10.1186/S12885-015-1421-8
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.4516
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.4569
A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary
HISTOPATHOLOGY
DOI:
10.1111/HIS.12253
PROGNOSTIC MARKERS FOR HIGH GRADE SEROUS OVARIAN CANCER AND VALIDATION USING LARGE SCALE NANOSTRING EXPRESSION PROFILING: AN OTTA CONSORTIUM STUDY
International Journal of Gynecological Cancer
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-14-1292
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
BRITISH JOURNAL OF CANCER
DOI:
10.1038/BJC.2014.567
Recurrent DICER1 hotspot mutations in endometrial cancer and their impact on microRNA biogenesis
CANCER RESEARCH
DOI:
10.1158/1538-7445.AM2014-544
ENHANCED GAB2 EXPRESSION IS CHARACTERISTIC OF A CLINICALLY DISTINCT PI3K-DEPENDENT SUBTYPE OF HIGH-GRADE SEROUS AND ENDOMETRIOID OVARIAN CANCER
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
PRACTICAL TECHNOLOGIES FOR MOLECULAR-BASED CLASSIFICATION TO IMPROVE MANAGEMENT IN WOMEN WITH ENDOMETRIAL CANCER
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
EXOME SEQUENCING OF LOW GRADE SEROUS OVARIAN TUMOURS
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
The somatic mutational landscape of ovarian clear cell carcinoma and its precursor lesions
CANCER RESEARCH
DOI:
10.1158/1538-7445.AM2014-LB-312
PROGNOSTIC MARKERS FOR HIGH GRADE SEROUS OVARIAN CANCER AND VALIDATION USING LARGE SCALE NANOSTRING EXPRESSION PROFILING: AN OTTA CONSORTIUM STUDY.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments
NANOMEDICINE
DOI:
10.2217/NNM.13.220
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
BMC CANCER
DOI:
10.1186/1471-2407-14-120
Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma
PLOS ONE
DOI:
10.1371/JOURNAL.PONE.0082406
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research.
Anglesio MS and Wiegand KC and Melnyk N and Chow C and Salamanca C and Prentice LM and Senz J and Yang W and Spillman MA and Cochrane DR and Shumansky K and Shah SP and Kalloger SE and Huntsman DG
PubMed:
24116245
FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines
MODERN PATHOLOGY
DOI:
10.1038/MODPATHOL.2012.226
Molecular profiling of low grade serous ovarian tumors
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.OVCA13-A13
The ovarian tumor tissue analysis (OTTA) consortium
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.OVCA13-A27
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.4088
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
LANCET ONCOLOGY
DOI:
10.1016/S1470-2045(13)70253-5
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.4230
Defining ovarian mucinous tumors: Cancer genes and heterogeneity
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.OVCA13-A18
Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review
HISTOPATHOLOGY
DOI:
10.1111/HIS.12219
A CURRENT PERSPECTIVE ON THE PATHOLOGICAL ASSESSMENT OF ADULT-TYPE GRANULOSA CELL TUMORS OF THE OVARY
International Journal of Gynecological Cancer
Rapid RNA-based histotyping of ovarian carcinomas
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.OVCA13-B14
A CURRENT PERSPECTIVE ON THE PATHOLOGICAL ASSESSMENT OF ADULT-TYPE GRANULOSA CELL TUMORS OF THE OVARY.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
PLOS ONE
DOI:
10.1371/JOURNAL.PONE.0072162
Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.4135
Cytokine gene expression signature in ovarian clear cell carcinoma
INTERNATIONAL JOURNAL OF ONCOLOGY
DOI:
10.3892/IJO.2012.1533
Benign serous ovarian tumour: a redefining moment?
Hunter S and Gorringe K and Anglesio M and Sharma R and Gilks B and deFazio A and Huntsman D and Campbell I
LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin
CANCER RESEARCH
DOI:
10.1158/0008-5472.CAN-12-0203
Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers
NEW ENGLAND JOURNAL OF MEDICINE
DOI:
10.1056/NEJMOA1102903
The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.4090
FOXL2 Molecular Testing in the Diagnosis of Ovarian Neoplasms
Laboratory Investigation
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
PLOS ONE
DOI:
10.1371/JOURNAL.PONE.0018064
Benign ovarian serous tumors: A redefining moment
CANCER RESEARCH
DOI:
10.1158/1538-7445.AM2011-LB-271
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
GYNECOLOGIC ONCOLOGY
DOI:
10.1016/J.YGYNO.2011.01.005
IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-10-3314
Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?
CLINICAL CANCER RESEARCH
DOI:
10.1158/1078-0432.CCR-11-2080
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
JOURNAL OF PATHOLOGY
DOI:
10.1002/PATH.2848
Identification of somatic mutations of the PPP2R1A gene in subtypes of endometrial and ovarian carcinomas
CANCER RESEARCH
DOI:
10.1158/1538-7445.AM2011-924
Using the right tools: A catalog of ovarian cancer cell lines by subtype
CANCER RESEARCH
DOI:
10.1158/1538-7445.AM2011-4289
Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
PLOS ONE
DOI:
10.1371/JOURNAL.PONE.0011408
Profiling the Cancer Genome
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 11
DOI:
10.1146/ANNUREV-GENOM-082509-141536
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
NEW ENGLAND JOURNAL OF MEDICINE
DOI:
10.1056/NEJMOA1008433
A dysregulated pathway underlying a novel molecular subtype of ovarian cancer
EJC SUPPLEMENTS
DOI:
10.1016/S1359-6349(09)70314-3
Are There Any More Ovarian Tumor Suppressor Genes? A New Perspective Using Ultra High-Resolution Copy Number and Loss of Heterozygosity Analysis
GENES CHROMOSOMES & CANCER
DOI:
10.1002/GCC.20694
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors
MOLECULAR CANCER RESEARCH
DOI:
10.1158/1541-7786.MCR-08-0193
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers
NATURE MEDICINE
DOI:
10.1038/NM1621
Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species
MOLECULAR AND CELLULAR BIOLOGY
DOI:
10.1128/MCB.26.1.277-292.2006
Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney
HUMAN MOLECULAR GENETICS
DOI:
10.1093/HMG/DDH215
